Company · CIK 1850119

# Century Therapeutics, Inc.

| CIK | [1850119](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001850119) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | PA |
| Listed | IPSC (Nasdaq) |
| First annual or quarterly report | 2021-08-12 |

## Offerings

 6 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-288616 | Shelf Effective | 2025-07-10 | 2026-03-26 | 3 |
| 333-293228 | Shelf Effective | 2026-02-05 | 2026-02-17 | 2 |
| 333-280310 | Shelf Effective | 2024-06-18 | 2024-06-26 | 2 |
| 333-279422 | Shelf Effective | 2024-05-15 | 2024-05-21 | 2 |
| 333-265975 | Shelf Effective | 2022-07-01 | 2022-07-13 | 2 |
| 333-256648 | IPO Final prospectus | 2021-05-28 | 2021-06-21 | 5 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-03-26 | [424B5](https://www.sec.gov/Archives/edgar/data/1850119/000110465926035255/0001104659-26-035255-index.htm) Shelf takedown | 333-288616 | 0001104659-26-035255 |
| 2026-02-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850119/999999999526000612/9999999995-26-000612-index.htm) Declared effective | 333-293228 | 9999999995-26-000612 |
| 2026-02-05 | [S-3](https://www.sec.gov/Archives/edgar/data/1850119/000110465926010885/0001104659-26-010885-index.htm) Shelf registered | 333-293228 | 0001104659-26-010885 |
| 2026-01-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850119/999999999526000127/9999999995-26-000127-index.htm) Declared effective | 333-288616 | 9999999995-26-000127 |
| 2025-07-10 | [S-3](https://www.sec.gov/Archives/edgar/data/1850119/000110465925067022/0001104659-25-067022-index.htm) Shelf registered | 333-288616 | 0001104659-25-067022 |
| 2024-06-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850119/999999999524001977/9999999995-24-001977-index.htm) Declared effective | 333-280310 | 9999999995-24-001977 |
| 2024-06-18 | [S-3](https://www.sec.gov/Archives/edgar/data/1850119/000110465924072855/0001104659-24-072855-index.htm) Shelf registered | 333-280310 | 0001104659-24-072855 |
| 2024-05-21 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850119/999999999524001609/9999999995-24-001609-index.htm) Declared effective | 333-279422 | 9999999995-24-001609 |
| 2024-05-15 | [S-3](https://www.sec.gov/Archives/edgar/data/1850119/000110465924061899/0001104659-24-061899-index.htm) Shelf registered | 333-279422 | 0001104659-24-061899 |
| 2022-07-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850119/999999999522002060/9999999995-22-002060-index.htm) Declared effective | 333-265975 | 9999999995-22-002060 |
| 2022-07-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1850119/000110465922076807/0001104659-22-076807-index.htm) Shelf registered | 333-265975 | 0001104659-22-076807 |
| 2021-06-21 | [424B4](https://www.sec.gov/Archives/edgar/data/1850119/000110465921082886/0001104659-21-082886-index.htm) Final prospectus | 333-256648 | 0001104659-21-082886 |
| 2021-06-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1850119/999999999521002398/9999999995-21-002398-index.htm) Declared effective | 333-256648 | 9999999995-21-002398 |
| 2021-06-15 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1850119/000110465921081561/0001104659-21-081561-index.htm) Amendment | 333-256648 | 0001104659-21-081561 |
| 2021-06-14 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1850119/000110465921080429/0001104659-21-080429-index.htm) Amendment | 333-256648 | 0001104659-21-080429 |
| 2021-05-28 | [S-1](https://www.sec.gov/Archives/edgar/data/1850119/000110465921074278/0001104659-21-074278-index.htm) Registration filed | 333-256648 | 0001104659-21-074278 |
| 2021-03-26 | [DRS](https://www.sec.gov/Archives/edgar/data/1850119/000110465921042551/0001104659-21-042551-index.htm) Draft made public | 377-04523 | 0001104659-21-042551 |

[All filings of this company](https://equitycapital.markets/filings?cik=1850119) · [CSV](https://equitycapital.markets/filings.csv?cik=1850119)

---
Source page: https://equitycapital.markets/company/1850119 · Data: U.S. SEC EDGAR · CC BY 4.0